Matsumoto S, Unoshima M, Takeshima N, Yamamoto H, Yoshitake S, Noguchi T
Division of Anesthesiology, Noguchi Thyroid Clinic, Beppu.
Masui. 2000 Sep;49(9):976-80.
This study was designed to investigate the effect of propofol on the heart rate and blood pressure in the patients on chronic beta-blocker. Seventy two hyperthyroidism patients scheduled for subtotal thyroidectomy were enrolled. Thirty six patients who were on chronic beta-blocker received either propofol (group beta-P) or thiamylal (group beta-T) as an anesthesia induction agent. In control groups, patients who were not on beta-blocker also received either propofol (group C-P) or thiamylal (group C-T). Anesthesia was maintained with nitrous oxide in oxygen and sevoflurane. Heart rate and systolic blood pressures were monitored and recorded before and during anesthesia. Heart rate decreased significantly in group beta-P compared to three other groups through this study. Significant decreases in systolic blood pressure were observed in the groups beta-P and beta-T compared to group C-P. These results suggest that careful attention should be paid to the patients on chronic beta-blocker when propofol was selected as an anesthesia induction agent.
本研究旨在探讨丙泊酚对长期服用β受体阻滞剂患者心率和血压的影响。纳入了72例计划行甲状腺次全切除术的甲亢患者。36例长期服用β受体阻滞剂的患者分别接受丙泊酚(β-P组)或硫喷妥钠(β-T组)作为麻醉诱导剂。在对照组中,未服用β受体阻滞剂的患者也分别接受丙泊酚(C-P组)或硫喷妥钠(C-T组)。麻醉维持采用氧化亚氮和七氟醚。在麻醉前和麻醉期间监测并记录心率和收缩压。通过本研究发现,与其他三组相比,β-P组心率显著下降。与C-P组相比,β-P组和β-T组收缩压显著下降。这些结果表明,当选择丙泊酚作为麻醉诱导剂时,应密切关注长期服用β受体阻滞剂的患者。